{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T23:22:49Z","timestamp":1778714569975,"version":"3.51.4"},"reference-count":43,"publisher":"Elsevier BV","issue":"1-2","license":[{"start":{"date-parts":[[2008,8,1]],"date-time":"2008-08-01T00:00:00Z","timestamp":1217548800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2008,8,1]],"date-time":"2008-08-01T00:00:00Z","timestamp":1217548800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jni-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Neuroimmunology"],"published-print":{"date-parts":[[2008,8]]},"DOI":"10.1016\/j.jneuroim.2008.06.002","type":"journal-article","created":{"date-parts":[[2008,7,8]],"date-time":"2008-07-08T05:58:46Z","timestamp":1215496726000},"page":"133-141","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":25,"title":["Antigen-specific apheresis of human anti-acetylcholine receptor autoantibodies from myasthenia gravis patients' sera using Escherichia coli-expressed receptor domains"],"prefix":"10.1016","volume":"200","author":[{"given":"Paraskevi","family":"Zisimopoulou","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"George","family":"Lagoumintzis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Konstantinos","family":"Poulas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Socrates J.","family":"Tzartos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jneuroim.2008.06.002_bib1","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1046\/j.1526-0968.2000.004004275.x","article-title":"Therapeutic apheresis in myasthenia gravis","volume":"4","author":"Batocchi","year":"2000","journal-title":"Ther. Apher."},{"key":"10.1016\/j.jneuroim.2008.06.002_bib2","doi-asserted-by":"crossref","first-page":"2843","DOI":"10.1172\/JCI29894","article-title":"Myasthenia gravis: past, present, and future","volume":"116","author":"Conti-Fine","year":"2006","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.jneuroim.2008.06.002_bib3","doi-asserted-by":"crossref","first-page":"2367","DOI":"10.1001\/jama.291.19.2367","article-title":"Intravenous immunoglobulin in autoimmune neuromuscular diseases","volume":"291","author":"Dalakas","year":"2004","journal-title":"Jama"},{"key":"10.1016\/j.jneuroim.2008.06.002_bib4","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.1056\/NEJM199406233302507","article-title":"Myasthenia gravis","volume":"330","author":"Drachman","year":"1994","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jneuroim.2008.06.002_bib5","first-page":"93","article-title":"Reduced acetylcholine receptors in myasthenia gravis","volume":"98","author":"Drachman","year":"1973","journal-title":"Trans. Am. Neurol. Ass."},{"key":"10.1016\/j.jneuroim.2008.06.002_bib6","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1126\/science.182.4109.293","article-title":"Neuromuscular junction in myasthenia gravis: decreased acetylcholine receptors","volume":"182","author":"Fambrough","year":"1973","journal-title":"Science"},{"key":"10.1016\/j.jneuroim.2008.06.002_bib7","doi-asserted-by":"crossref","first-page":"799","DOI":"10.2217\/14796708.1.6.799","article-title":"Recent advances in the understanding and therapy of myasthenia gravis","volume":"1","author":"Fostieri","year":"2006","journal-title":"Future Neurol."},{"key":"10.1016\/j.jneuroim.2008.06.002_bib8","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.jim.2005.04.013","article-title":"Preparation of an immunoadsorbent coupled with a recombinant antigen to remove anti-acetylcholine receptor antibodies in abnormal serum","volume":"303","author":"Guo","year":"2005","journal-title":"J. Immunol. Methods"},{"key":"10.1016\/j.jneuroim.2008.06.002_bib9","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1038\/85520","article-title":"Auto-antibodies to the receptor tyrosine kinase MuSK in patients with myasthenia gravis without acetylcholine receptor antibodies","volume":"7","author":"Hoch","year":"2001","journal-title":"Nat. Med."},{"key":"10.1016\/j.jneuroim.2008.06.002_bib10","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1038\/nrn731","article-title":"Emerging structure of the nicotinic acetylcholine receptors","volume":"3","author":"Karlin","year":"2002","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.jneuroim.2008.06.002_bib11","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1002\/mus.20030","article-title":"Clinical evaluation and management of myasthenia gravis","volume":"29","author":"Keesey","year":"2004","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.jneuroim.2008.06.002_bib12","doi-asserted-by":"crossref","first-page":"3557","DOI":"10.1111\/j.1742-4658.2006.05363.x","article-title":"Expression and characterization of soluble forms of the extracellular domains of the beta, gamma and epsilon subunits of the human muscle acetylcholine receptor","volume":"273","author":"Kostelidou","year":"2006","journal-title":"FEBS J."},{"key":"10.1016\/j.jneuroim.2008.06.002_bib13","doi-asserted-by":"crossref","DOI":"10.1016\/j.jneuroim.2007.07.018","article-title":"Extracellular domains of the beta, gamma and epsilon subunits of the human acetylcholine receptor as immunoadsorbents for myasthenic autoantibodies: a combination of immunoadsorbents results in increased efficiency","author":"Kostelidou","year":"2007","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.jneuroim.2008.06.002_bib14","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/S0955-3886(98)00022-8","article-title":"Plasmapheresis in myasthenia gravis. A survey","volume":"19","author":"Kuks","year":"1998","journal-title":"Transfus. Sci."},{"key":"10.1016\/j.jneuroim.2008.06.002_bib15","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/0022-510X(93)90132-I","article-title":"Antibodies to skeletal muscle in myasthenia gravis. Part 1. Diagnostic value for the detection of thymoma","volume":"119","author":"Kuks","year":"1993","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.jneuroim.2008.06.002_bib16","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1002\/neu.10153","article-title":"The diversity of subunit composition in nAChRs: evolutionary origins, physiologic and pharmacologic consequences","volume":"53","author":"Le Novere","year":"2002","journal-title":"J. Neurobiol."},{"key":"10.1016\/j.jneuroim.2008.06.002_bib17","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1146\/annurev.iy.03.040185.000545","article-title":"Immunobiology of myasthenia gravis, experimental autoimmune myasthenia gravis, and Lambert-Eaton syndrome","volume":"3","author":"Lindstrom","year":"1985","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.jneuroim.2008.06.002_bib18","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1002\/mus.880010206","article-title":"Specificities of antibodies to acetylcholine receptors","volume":"1","author":"Lindstrom","year":"1978","journal-title":"Muscle Nerve"},{"issue":"Pt C","key":"10.1016\/j.jneuroim.2008.06.002_bib19","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1016\/0076-6879(81)74031-X","article-title":"Production and assay of antibodies to acetylcholine receptors","volume":"74","author":"Lindstrom","year":"1981","journal-title":"Methods Enzymol."},{"key":"10.1016\/j.jneuroim.2008.06.002_bib20","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1002\/(SICI)1097-4598(200004)23:4<453::AID-MUS3>3.0.CO;2-O","article-title":"Acetylcholine receptors and myasthenia","volume":"23","author":"Lindstrom","year":"2000","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.jneuroim.2008.06.002_bib21","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1084\/jem.144.3.739","article-title":"Pathological mechanisms in experimental autoimmune myasthenia gravis. II. Passive transfer of experimental autoimmune myasthenia gravis in rats with anti-acetylcholine receptor antibodies","volume":"144","author":"Lindstrom","year":"1976","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.jneuroim.2008.06.002_bib22","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1212\/WNL.26.11.1054","article-title":"Antibody to acetylcholine receptor in myasthenia gravis. Prevalence, clinical correlates, and diagnostic value","volume":"26","author":"Lindstrom","year":"1976","journal-title":"Neurology."},{"key":"10.1016\/j.jneuroim.2008.06.002_bib23","doi-asserted-by":"crossref","first-page":"2949","DOI":"10.1002\/eji.1830221129","article-title":"Use of Torpedo-mouse hybrid acetylcholine receptors reveals immunodominance of the alpha subunit in myasthenia gravis antisera","volume":"22","author":"Loutrari","year":"1992","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.jneuroim.2008.06.002_bib24","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/S0733-8619(05)70335-2","article-title":"Acquired myasthenia gravis","volume":"15","author":"Massey","year":"1997","journal-title":"Neurol. Clin."},{"key":"10.1016\/j.jneuroim.2008.06.002_bib25","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/S0140-6736(79)90823-7","article-title":"Long-term effects of repeated plasma exchange in myasthenia gravis","volume":"1","author":"Newsom-Davis","year":"1979","journal-title":"Lancet"},{"key":"10.1016\/j.jneuroim.2008.06.002_bib26","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1126\/science.180.4088.871","article-title":"Autoimmune response to acetylcholine receptor","volume":"180","author":"Patrick","year":"1973","journal-title":"Science"},{"key":"10.1016\/j.jneuroim.2008.06.002_bib27","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1136\/jnnp.71.3.352","article-title":"Epidemiology of seropositive myasthenia gravis in Greece","volume":"71","author":"Poulas","year":"2001","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.jneuroim.2008.06.002_bib28","doi-asserted-by":"crossref","first-page":"26980","DOI":"10.1074\/jbc.M110731200","article-title":"Expression of soluble ligand- and antibody-binding extracellular domain of human muscle acetylcholine receptor alpha subunit in yeast Pichia pastoris. Role of glycosylation in alpha-bungarotoxin binding","volume":"277","author":"Psaridi-Linardaki","year":"2002","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jneuroim.2008.06.002_bib29","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1196\/annals.1254.071","article-title":"Future therapeutic strategies in autoimmune myasthenia gravis","volume":"998","author":"Psaridi-Linardaki","year":"2003","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.jneuroim.2008.06.002_bib30","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.jneuroim.2004.10.002","article-title":"Specific immunoadsorption of the autoantibodies from myasthenic patients using the extracellular domain of the human muscle acetylcholine receptor alpha-subunit. Development of an antigen-specific therapeutic strategy","volume":"159","author":"Psaridi-Linardaki","year":"2005","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.jneuroim.2008.06.002_bib31","doi-asserted-by":"crossref","first-page":"1652","DOI":"10.1212\/01.WNL.0000098887.24618.A0","article-title":"Treatment of autoimmune myasthenia gravis","volume":"61","author":"Richman","year":"2003","journal-title":"Neurology"},{"key":"10.1016\/j.jneuroim.2008.06.002_bib32","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1136\/jnnp.65.4.492","article-title":"Myasthenia gravis: a population based epidemiological study in Cambridgeshire, England","volume":"65","author":"Robertson","year":"1998","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.jneuroim.2008.06.002_bib33","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1007\/s004150050604","article-title":"Muscle autoantibodies in subgroups of myasthenia gravis patients","volume":"247","author":"Romi","year":"2000","journal-title":"J. Neurol."},{"key":"10.1016\/j.jneuroim.2008.06.002_bib34","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.jneuroim.2007.06.014","article-title":"Isolation and functional characterization of anti-acetylcholine receptor subunit-specific autoantibodies from myasthenic patients: receptor loss in cell culture","volume":"189","author":"Sideris","year":"2007","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.jneuroim.2008.06.002_bib35","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.coph.2005.01.010","article-title":"Myasthenia gravis: emerging new therapy options","volume":"5","author":"Sieb","year":"2005","journal-title":"Curr. Opin. Pharmacol."},{"key":"10.1016\/j.jneuroim.2008.06.002_bib36","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1111\/j.1468-1331.2006.01476.x","article-title":"Guidelines for the treatment of autoimmune neuromuscular transmission disorders","volume":"13","author":"Skeie","year":"2006","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.jneuroim.2008.06.002_bib37","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1046\/j.1526-0968.2001.00367.x","article-title":"Immunoadsorption in myasthenia gravis based on specific ligands mimicking the immunogenic sites of the acetylcholine receptor","volume":"5","author":"Takamori","year":"2001","journal-title":"Ther. Apher."},{"key":"10.1016\/j.jneuroim.2008.06.002_bib38","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1093\/intimm\/12.9.1255","article-title":"Reconstitution of conformationally dependent epitopes on the N-terminal extracellular domain of the human muscle acetylcholine receptor alpha subunit expressed in Escherichia coli: implications for myasthenia gravis therapeutic approaches","volume":"12","author":"Tsouloufis","year":"2000","journal-title":"Int. Immunol."},{"key":"10.1016\/j.jneuroim.2008.06.002_bib39","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1073\/pnas.79.1.188","article-title":"Specificities of antibodies to acetylcholine receptors in sera from myasthenia gravis patients measured by monoclonal antibodies","volume":"79","author":"Tzartos","year":"1982","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jneuroim.2008.06.002_bib40","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1111\/j.1600-065X.1998.tb01190.x","article-title":"Anatomy of the antigenic structure of a large membrane autoantigen, the muscle-type nicotinic acetylcholine receptor","volume":"163","author":"Tzartos","year":"1998","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.jneuroim.2008.06.002_bib41","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1016\/j.jmb.2004.12.031","article-title":"Refined structure of the nicotinic acetylcholine receptor at 4A resolution","volume":"346","author":"Unwin","year":"2005","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.jneuroim.2008.06.002_bib42","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1038\/nri916","article-title":"Unravelling the pathogenesis of myasthenia gravis","volume":"2","author":"Vincent","year":"2002","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.jneuroim.2008.06.002_bib43","doi-asserted-by":"crossref","first-page":"2122","DOI":"10.1016\/S0140-6736(00)05186-2","article-title":"Myasthenia gravis","volume":"357","author":"Vincent","year":"2001","journal-title":"Lancet"}],"container-title":["Journal of Neuroimmunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165572808001847?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165572808001847?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T08:09:01Z","timestamp":1759046941000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165572808001847"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,8]]},"references-count":43,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2008,8]]}},"alternative-id":["S0165572808001847"],"URL":"https:\/\/doi.org\/10.1016\/j.jneuroim.2008.06.002","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.1120623.576839","asserted-by":"object"}]},"ISSN":["0165-5728"],"issn-type":[{"value":"0165-5728","type":"print"}],"subject":[],"published":{"date-parts":[[2008,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Antigen-specific apheresis of human anti-acetylcholine receptor autoantibodies from myasthenia gravis patients' sera using Escherichia coli-expressed receptor domains","name":"articletitle","label":"Article Title"},{"value":"Journal of Neuroimmunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jneuroim.2008.06.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2008 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}